coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Dean's And Central Brighton PCN, Brighton and Hove (LAD) · Health Inequalities Profile

    PCN U22426 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    35,505

    Registered population

    69.5% aged 18–64

    16.5%

    Aged 65+

    ICB 21.9% · England 17.9%

    15.3%

    Ethnic minority (non-White)

    5.2% Asian · England 9.6%

    27.8%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~8,177

    Core20 residents (est.)

    Resident basis; registered basis ~10,460 · see page 3

    3,893

    Hypertension register

    +10.77% in 3 yrs · England +5.60%

    493

    SMI register

    10.6% of Brighton and Hove (LAD)'s

    596

    COPD register

    Reviews +7.24% in 3 yrs

    Forecast to 2030

    4,746

    Hypertension patients, 2030

    +853 on today

    74.2%

    QRISK ≥20% on statins, 2030

    +5.40pp over 3 yrs

    4.1%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    62.7 pp
    Wide practice spread in phone access.

    Phone contact ease spans from 19.1% at The Avenue Surgery to 81.8% at Ship Street Surgery (England 56.9%), which may reflect unverified capacity differences.

    62.8%
    Asthma reviews and cancer screening lag England.

    Asthma review coverage is 62.8% (England 65.7%), while cervical screening (25-49 yrs) is 54.8% (England 66.8%) and breast screening is 61.9% (England 69.9%).

    94.1%
    High BP recording, lower treatment conversion.

    Hypertension BP recording reaches 94.1% (England 90.0%), though treatment to target (69.0% vs 70.3%) and high-risk lipid therapy (61.8% vs 63.6%) trail England.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Working-age adults form 69.5% of registered patients alongside 5,868 patients aged 65+

    Dean's and Central Brighton PCN serves 35,505 registered patients across five practices. Working-age adults aged 18-64 represent 69.5% of the list, below Brighton and Hove (LAD) at 71.4% but above NHS Sussex Integrated Care Board (60.5%) and England (62.7%). Older adults aged 65+ make up 16.5% (5,868 patients), above the LAD (14.0%) but below the ICB (21.9%) and England (17.9%). Children aged 0-17 comprise 13.9% (LAD 15.0%, ICB 17.7%, England 19.6%). Census figures show 84.7% of local residents are White (LAD 85.4%, ICB 91.0%, England 81.1%), which reflects area residents rather than registered patients.

    Age profile

    0–1713.9%
    18–6469.5%
    65+16.5%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White84.7%
    Asian5.2%
    Mixed4.7%
    Other2.9%
    Black2.6%

    Older people · falls rows are Brighton and Hove (LAD) local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Brighton and Hove LA)2,7022,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)76.6%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)57.1%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Brighton and Hove LA)1,4859819552024/25
    Falls deaths, all ages, per 100,000 (Brighton and Hove LA)19.914.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 share reaches 27.8% but spans 59.6 percentage points across practices

    The PCN Core20 cohort is 27.8%, above Brighton and Hove (LAD) at 17.6%, NHS Sussex Integrated Care Board at 9.2% and England at 21.0%. An average IMD decile of 5.1 masks a 59.6 pp practice spread, ranging from Saltdean And Rottingdean Med Practice at 0.9% to The Avenue Surgery at 60.5%. Practice-level registered estimates sum to 10,460 patients, while the PCN resident estimate is 8,177. Prioritising inequality outreach requires balancing concentration at The Avenue Surgery (3,912 patients) against absolute volume at Brighton Station Health Centre (3,174 patients).

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Avenue60.5% · 3,912 patients
    School House49.1% · 2,443 patients
    Brighton Station36.9% · 3,174 patients
    Ship Street31.1% · 818 patients
    Saltdean And0.9% · 113 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    493

    SMI register

    1.35% recorded prevalence

    211

    Learning disability register

    0.58% recorded prevalence

    19

    Care homes, 484 beds

    In the PCN catchment

    8.2%

    Provide unpaid care

    Brighton and Hove (LAD), Census 2021

    Severe mental illness prevalence is 1.4% (493 patients), matching Brighton and Hove (LAD) (1.4%) and above NHS Sussex Integrated Care Board (1.1%) and England (1.0%). Learning disability prevalence is 0.6% (211 patients), matching all benchmarks. Catchment services cover 19 care homes with 484 beds. The SMI register is above the England rate, so physical-health checks for this cohort are the key workload to protect.

    Severe mental illness: physical health checks

    SMI blood pressure checks reach 78.3% (England 83.4%), spanning 65.6% at Brighton Station Health Centre and 71.8% at School House Surgery. BMI recording is 75.4% (England 82.1%) and alcohol recording is 72.0% (England 81.8%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    3,893

    Hypertension register

    +10.77%

    Register growth, 3 yrs

    Brighton and Hove (LAD) +7.27% · England +5.60%

    +4.62pp

    BP control, under 80

    ≤140/90 · +2.02pp aged 80+

    +853

    More patients by 2030

    Forecast 4,746 (13.07%)

    Hypertension case-finding and control

    Hypertension QOF prevalence is 10.7% (3,893 patients), in line with Brighton and Hove (10.5%) but below NHS Sussex Integrated Care Board (16.3%) and England (15.2%), though crude prevalence is not age-adjusted. Blood pressure recording is high at 94.1%, exceeding the borough (88.6%), ICB (90.2%) and England (90.0%). However, treatment to target reaches 69.0%, trailing England (70.3%) and the ICB (69.1%) despite exceeding the borough (66.5%), with blood pressure controlled to <= 140/90 mmHg in 67.2% of patients aged under 80 (England 67.8%). Treatment to target lags national benchmarks despite strong blood pressure monitoring, so prioritising medication escalation for uncontrolled patients is the key operational opportunity.

    Lipids and statins

    Patients with QRISK >= 20% on lipid-lowering therapy reach 61.8%, above the borough (58.9%) and ICB (60.0%) but below England (63.6%). Fewer at-risk patients receive lipid-lowering therapy than national rates imply, making proactive recall for high QRISK patients the immediate priority.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202645,524£2.30£2.42£1.86£104,705
    Cardiovascular (all), 202565,254£2.96£3.32£3.33£193,152

    In 2026, the PCN prescribed 45,524 lipid-modifying items at £2.30 per item, below Brighton and Hove (£2.47) and NHS Sussex Integrated Care Board (£2.42) but above England (£1.86), spending £20,031 more than at England's unit cost. Higher unit cost than England highlights an opportunity to review lipid-modifying formulary choices where clinically appropriate.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +5.90%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.24%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 5.7% (2,024 patients), with annual review coverage at 62.8% (England 65.7%; Brighton and Hove 60.1%), leaving about 750 patients without a recorded review. Meanwhile, asthma prescribing for ages 5-19 reaches 1,728 items per 1,000 (England 1,488), yet youth second-hand smoke recording is 70.8% (England 78.8%). COPD prevalence is 1.6% (596 patients) with 76.2% reviewed (England 76.4%). High youth prescribing alongside review gaps could indicate uncontrolled disease, which clinical review would test.

    Cancer register and children's immunisation

    The cancer register records 1,167 patients (3.2% prevalence, England 3.8%). Childhood immunisations lag behind the 95.0% target: MMR dose 1 coverage at 24 months is 81.8% (13.2 pp below target; England 88.3%), and the 4-in-1 booster at age 5 is 81.4% (13.6 pp below target; England 80.9%). At age 5, second-dose MMR is 83.1% against 89.8% for first dose (a 6.7 pp dose gap).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months91.2%

    England 91.0%

    6-in-1 complete primary course at 24 months90.9%

    England 92.2%

    MMR dose 1 at 24 months81.8%

    England 88.3%

    MMR dose 2 at age 583.1%

    England 82.8%

    4-in-1 pre-school booster at age 581.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In NHS Sussex ICB in 2022, 58.5% of staged cancers (4,799 of 8,209) were diagnosed at stage 1 or 2, above England (55.3%) but below the 75.0% national ambition by 16.5 pp, with stage known for 64.3% of registrations (England 67.0%). Closing this gap across the ICB would require about 1,360 additional early diagnoses. Cervical early-stage diagnosis in the ICB is 58.2% (England 67.6%). Locally, cervical screening in women aged 25-49 is 54.8% (Brighton and Hove 60.5%, England 66.8%) and breast screening is 61.9% (England 69.9%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), University Hospitals Sussex NHS Foundation Trust achieved 65.2% on the cancer 62-day standard, trailing the 85.0% standard by 19.8 pp, below NHS Surrey and Sussex ICB (71.5%) and England (71.2%). East Sussex Healthcare NHS Trust reached 67.0% and Surrey and Sussex Healthcare NHS Trust reached 70.0%. The 28-day faster diagnosis standard was 74.0% (standard 75.0%), and the 31-day combined standard was 76.8% (standard 96.0%). Diagnostics show 5.6% waiting 6+ weeks for MRI and 8.6% for CT (England 21.4% and 9.9%). These figures reflect trust performance rather than exclusive PCN pathways.

    Pathways within standard (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0184.2077.7479.2979.32
    31-day treatment (96%)76.7998.1996.2090.4592.50
    62-day referral to treatment (85%)65.2067.0469.9771.5171.16
    Diagnostic waits over 6 weeks (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareEngland
    MRI5.626.4827.5321.40
    CT8.570.4818.499.92
    Echocardiography0.3921.9443.7828.48
    Colonoscopy39.350.7415.1130.83
    Gastroscopy20.020.3121.0629.02
    All 15 DM01 tests12.955.2728.5023.14
    Community services activityBrighton and Hove residentsSurrey and Sussex ICB
    Care contacts23,615309,615
    Referrals5,59066,930
    Patients with a contact7,35085,660

    Community services (residents of Brighton and Hove), Jun 2026 (provisional). In June 2026 (provisional), community health service records show 23,615 total contacts for Brighton and Hove residents, of which 14,325 contacts (60.7%) were with adults aged 65 and older. This reflects activity across the local authority rather than PCN-level activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 62.7 pp between practices while clinical QOF achievement remains high

    Clinical QOF achievement ranges from 95.3% at School House Surgery to 99.7% at Brighton Station Health Centre (England 97.1%). Vaccination achievement spans 40.1 pp, from 23.8% at Ship Street Surgery to 63.8% at Saltdean And Rottingdean Med Practice (England 55.2%). Personalised care adjustments reach 7.8% at Saltdean And Rottingdean Med Practice and 15.0% at School House Surgery (England 10.0%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Ship Street10831.181.8%67.4%90.1%
    Saltdean And1000.952.4%72.9%74.2%
    Brighton Station12236.965.4%82.2%70.5%
    School House8349.150.6%74.7%68.0%
    The Avenue Surgery10060.519.1%80.7%59.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBrighton and Hove (LAD)AssetPCNBrighton and Hove (LAD)
    Care homes (catchment)19 (484 beds)n/aSchools (catchment)48n/a
    Children's centres414Places of worship44113
    Libraries513Homelessness support (VCS)0no data
    Primary schools (LA maintained)1035Primary academies27
    Special schoolsn/a2

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and youth recall

    Asthma review coverage is 62.8% (England 65.7%; Brighton and Hove (LAD) 60.1%) across 2,024 patients (about 750 unreviewed), while youth asthma prescribing is 1,728 per 1,000 (England 1,488). For discussion: practices could run structured asthma review and inhaler check recall using flexible after-school or holiday slots, prioritising high-deprivation lists. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Combined SMI physical health check outreach

    Across the 493-patient SMI register, annual blood pressure checks reach 78.3% (England 83.4%), BMI recording 75.4% (England 82.1%) and alcohol recording 72.0% (England 81.8%). For discussion: the PCN could introduce combined single-visit SMI physical check clinics, dedicated outreach for non-attenders, and liaison raised with system mental health partners. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Hypertension and lipid therapy escalation

    On the 3,893-patient hypertension register, blood pressure recording is 94.1% (England 90.0%), but treatment to target is 69.0% (England 70.3%) and QRISK >= 20% lipid therapy is 61.8% (England 63.6%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Working age access review (p2)Aged 18-64Neighbourhood health frameworkPCN
    Targeted Core20 outreach and reconciliation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension medication escalation audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool immunisation outreach (p6)MMR dose 1 coverage at 24 months10YHP sickness to prevention · 95% targetPCN
    Screening recall and engagement audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma review and youth recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Combined SMI physical health check outreach (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN & Practice
    Option 3 · Hypertension and lipid therapy escalation (p12)Hypertension register · Hypertension patients with a recent BP reading · Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15